TFF Pharmaceuticals Inc. (TFFP) Misses Q4 EPS by 3c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. DECK
2. RNG
3. WDC
4. BMY
5. BYD
6. WCN
7. SPOT
8. SPY
9. FIX
10. TSCO

Go back to TFF Pharmaceuticals Inc. (TFFP) Misses Q4 EPS by 3c

TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and Business Results

March 10, 2021 4:00 PM EST

Reports positive Phase 1 study results for Voriconazole Inhalation Powder and Tacrolimus Inhalation Powder

Awarded subcontract license by U.S. government agency to formulate biologic countermeasures to be used by the U.S. military

Announces feasibility agreements with Greenlight Biosciences for Covid-19 mRNA Vaccine Reformulation and NeuroRx for Covid-19 therapeutic for critically ill patients

Conference call and live webcast scheduled today, Wednesday, March 10, 2021 at 4:30pm EST

AUSTIN, Texas--(BUSINESS WIRE)-- TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical... More